Ex­clu­sive: No­cion rais­es $62M for dif­fer­ent ap­proach to chron­ic cough than Mer­ck, GSK

In the mid­dle of 2023, Richard Baty­cky told a cou­ple of his fel­low ex­ec­u­tives at No­cion Ther­a­peu­tics to con­sid­er look­ing for roles else­where. He wasn’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.